The Oxford laser prostate trial: Sensitivity to change of three measures of outcome

被引:17
作者
Keoghane, SR
Lawrence, KC
Jenkinson, CP
Doll, HA
Chappel, DB
机构
[1] CHURCHILL HOSP,DEPT UROL,OXFORD OX3 7LJ,ENGLAND
[2] DEPT PUBL HLTH & PRIMARY CARE,HLTH SERV RES UNIT,OXFORD,ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0090-4295(99)80380-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURF) and contact laser prostatectomy. Methods. A total of 152 patients were randomized to TUFF or contact laser prostatectomy using the Surgical Laser Technology (SLT) system. Preoperative data were obtained using a self-administered questionnaire containing the American Urological Association (AUA-7) symptom score, the bothersome score (benign prostatic hyperplasia impact index), and the Short Form-36 health status questionnaire (SF-36). Follow-up was at and 3 months. Effect size scores were calculated to indicate the extent of change from baseline to follow-up. Results. Data were available on 148 patients: 72 received laser therapy and 76 received TURF. Mean change in AUA-7 score at 3 months was 7.3 in the laser arm, compared with 11.9 in the TURF arm (P < 0.05). Furthermore, substantial change was detected in both groups on the bothersome score. However, very few significant differences in SF-36 dimension scores from baseline to 3 months were detected. Conclusions. The SF-36 at both baseline and follow-up indicated a similar level of health status as that reported in the general population. Subsequently, the measure did not improve on any dimensions. Our data support the claim of some researchers that shorter disease-specific indices are vital to the evaluation of treatment regimens in clinical trials, especially when the general health of the patients is similar to that of the population.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 22 条
  • [1] [Anonymous], APPL SOCIAL SCI CLIN
  • [2] Barry Michael J., 1995, Journal of Urology, V153, p319A
  • [3] THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    FOWLER, FJ
    OLEARY, MP
    BRUSKEWITZ, RC
    HOLTGREWE, HL
    MEBUST, WK
    COCKETT, ATK
    BLAIVAS, JG
    WEIN, AJ
    [J]. JOURNAL OF UROLOGY, 1992, 148 (05) : 1549 - 1557
  • [4] MEASUREMENT OF HEALTH-STATUS
    BERGNER, M
    [J]. MEDICAL CARE, 1985, 23 (05) : 696 - 704
  • [5] VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE
    BRAZIER, JE
    HARPER, R
    JONES, NMB
    OCATHAIN, A
    THOMAS, KJ
    USHERWOOD, T
    WESTLAKE, L
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846): : 160 - 164
  • [6] COHEN J, 1977, STATISTICAL POWER BE
  • [7] COULTER A, 1993, CRITICAL READING GEN, P115
  • [8] PATIENT-PERCEIVED HEALTH-STATUS BEFORE AND UP TO 12 MONTHS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERTROPHY
    DOLL, HA
    BLACK, NA
    FLOOD, AB
    MCPHERSON, K
    [J]. BRITISH JOURNAL OF UROLOGY, 1993, 71 (03): : 297 - 305
  • [9] EMBERTON M, 1994, NATIONAL PROSTATECTO
  • [10] Hunt S, 1986, MEASURING HLTH STATU